FDAnews
www.fdanews.com/articles/61070-center-to-boost-biomanufacturing-in-england

CENTER TO BOOST BIOMANUFACTURING IN ENGLAND

July 21, 2006

Momentum is growing at the UK's new National Biomanufacturing Centre (NBC) as Eden Biodesign inked a second contract at the center — set up to establish Northwest England as one of the top biomanufacturing hubs in Europe.

Under the new contract, Eden will develop and manufacture monoclonal antibodies against a novel cancer antigen, to be used in investigational cancer-killing drugs being developed by the University of Liverpool.

The UK is now second only to the U.S. in terms of its biopharmaceuticals development pipeline; however, the country's industry still lags a long way behind the U.S., and the UK government has been making a concerted effort to close this gap.

The NBC, which officially opens later this year, is a £34.3 million (⁈49.8 million) government-funded initiative led by the Northwest Regional Development Agency to assist UK academia in developing and commercializing their biopharma discoveries.